研究用抗体の世界市場:製品別、種類別(単クローン、多クローン)、技術別、ソース別、用途別(腫瘍学、神経生物学)、最終用途別、セグメント予測

【英語タイトル】Research Antibodies Market Size, Share & Trends Analysis Report By Product, By Type (Monoclonal, Polyclonal), By Technology, By Source, By Application (Oncology, Neurobiology), By End-use, And Segment Forecasts, 2018 - 2025

Grand View Researchが出版した調査資料(GVIEW805075)・商品コード:GVIEW805075
・発行会社(調査会社):Grand View Research
・発行日:2018年3月22日
・ページ数:142
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・調査対象地域:グローバル
・産業分野:Biotechnology
◆販売価格オプション(消費税別)
Single UserUSD5,950 ⇒換算¥672,350見積依頼/購入/質問フォーム
Multi UserUSD7,950 ⇒換算¥898,350見積依頼/購入/質問フォーム
Global/corporate LicenseUSD9,950 ⇒換算¥1,124,350見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本調査レポートでは、研究用抗体の世界市場について調査・分析し、研究用抗体の世界市場動向、研究用抗体の世界市場規模、市場予測、セグメント別研究用抗体市場分析、主要地域別市場規模、競争状況、関連企業情報などを含め、以下の構成でお届け致します。
【レポートの概要】

The global research antibodies market size is expected to reach USD 4.30 billion by 2025, according to a new report by Grand View Research, Inc., expanding at a CAGR of 6.1% during the forecast period. The market is predominantly driven by growing number of R&D collaborations among various public and private organizations to promote technical advancements in product development activities and disease progression studies. Consistent recommendations and guidelines issued by regulatory organizations for laboratories to facilitate generation of accurate results and ensure high-quality standards are slated to enhance adoption of research antibodies over the coming years. For instance, in May 2016, the International Society for Stem Cell Research issued revised guidelines for cell-based therapies. The revised guidelines were issued with a focus to improve overall efficiency and quality of preclinical studies.
In addition, prominent market players are entering into partnership with R&D entities that are anticipated to open new avenues. In December 2016, Bayer AG and Versant Ventures collaborated to invest around USD 225.0 million for the establishment of a stem cell research facility in Canada to encourage commercialization of regenerative medicine therapies. Increasing prevalence of breast cancer and soaring need for personalized medicine is stirring up the demand for advanced techniques, which in turn is creating ample growth opportunities for the research antibodies market.

Further key findings from the report suggest:

• Primary antibodies were the most prominent product segment in 2016 owing to greater specificity leading to increased adoption in research activities. The segment is expected to account for more than 65.0% of the overall market revenue by 2025

• On the basis of type, monoclonal antibodies captured substantial share of the market in 2016, owing to high sensitivity for detection of antigens and efficient staining properties with less background noise. The segment is anticipated to rise at a CAGR of 6.6% during the forecast period

• Western blotting commanded the leading share in the market, due to benefits such as better immunogenic response from infectious agents and higher cost efficiency. The immunoprecipitation segment is estimated to post the highest CAGR of just over 7.0% during the same period

• Mouse antibodies are relatively easier to produce and possess greater specificity, thus resulting in higher adoption in R&D and accounting for the largest market share in 2016.

• Oncology accounted for over 36.0% of the overall revenue in 2016 as a consequence of growing cancer population

• Pharmaceutical & biotechnology companies will be the leading end users of research antibodies owing to increased adoption in drug development and discovery. The segment is poised to represent more than 61.0% of the overall revenue by 2025.

• Contract research organizations are likely to be the most promising end-user segment during the forecast period owing to greater cost efficiency

• North America will continue to be the dominant revenue contributor throughout the forecast period owing to local presence of various biotechnology & biopharmaceutical manufacturers striving to compete in the market

• Some of the key players in the global arena are Abcam PLC; Agilent Technologies; and Thermo Fisher Scientific, Inc. The research antibodies market is moderately consolidated and highly competitive due to low entry barriers.

【レポートの目次】

Table of Contents

Chapter 1 Executive Summary
1.1 Market Snapshot
Chapter 2 Research Methodology & Scope
2.1 Region Wise Market Calculation
2.1.1 Region Wise Market: Base Estimates
2.1.2 Global Market: CAGR Calculation
2.2 Region based segment share calculation
2.3 List of Secondary Sources
Chapter 3 Research Antibodies Market Variables, Trends& Scope
3.1 Market Segmentation& Scope
3.2 Market Driver Analysis
3.2.1 Increasing investment in R&D
3.2.2 Growing stem cells and neurobiology research
3.3 Market Restraint Analysis
3.3.1 Stringent government regulations
3.4 Penetration & Growth Prospect Mapping
3.5 Research Antibodies – SWOT Analysis, By Factor (Political & legal, economic and technological)
3.6 Industry Analysis – Porter’s
Chapter 4 Research Antibodies Market: Product Estimates & Trend Analysis
4.1 Research antibodies Market: Product Movement Analysis
4.2 Primary Antibodies
4.2.1 Primary antibodies market, 2014 – 2025 (USD Million)
4.3 Secondary Antibodies
4.3.1 Secondary antibodies market, 2014 – 2025 (USD Million)
Chapter 5 Research Antibodies Market: Type Estimates & Trend Analysis
5.1 Research Antibodies Market: Type Movement Analysis
5.2 Monoclonal Antibodies
5.2.1 Monoclonal Antibodies market, 2014 – 2025 (USD Million)
5.3 Polyclonal Antibodies
5.3.1 Polyclonal Antibodies market, 2014 – 2025 (USD Million)
Chapter 6 Research Antibodies Market: Technology Estimates & Trend Analysis
6.1 Research antibodies Market: Technology Movement Analysis
6.2 Immunohistochemistry
6.2.1 Immunohistochemistry market, 2014 – 2025 (USD Million)
6.3 Immunofluorescence
6.3.1 Immunofluorescene market, 2014 – 2025 (USD Million)
6.4 Western Blotting
6.4.1 Western blotting market, 2014 – 2025 (USD Million)
6.5 Flow Cytometry
6.5.1 Flow Cytometry market, 2014 – 2025 (USD Million)
6.6 Immunoprecipitation
6.6.1 Immunoprecipitation market, 2014 – 2025 (USD Million)
6.7 Enzyme – linked Immunoassay
6.7.1 ELISA market, 2014 – 2025 (USD Million)
6.8 Others
6.8.1 Others market, 2014 – 2025 (USD Million)
Chapter 7 Research Antibodies Market: Source Estimates & Trend Analysis
7.1 Research antibodies Market: Source Movement Analysis
7.2 Mouse
7.2.1 Mouse market, 2014 – 2025 (USD Million)
7.3 Rabbit
7.3.1 Rabbit market, 2014 – 2025 (USD Million)
7.4 Goat
7.4.1 Goat market, 2014 – 2025 (USD Million)
7.5 Others
7.5.1 Others market, 2014 – 2025 (USD Million)
Chapter 8 Research Antibodies Market: Application Estimates & Trend Analysis
8.1 Research antibodies Market: Application Movement Analysis
8.2 Infectious Diseases
8.2.1 Infectious diseases market, 2014 – 2025 (USD Million)
8.3 Immunology
8.3.1 Immunology market, 2014 – 2025 (USD Million)
8.4 Oncology
8.4.1 Oncology market, 2014 – 2025 (USD Million)
8.5 Stem Cells
8.5.1 Stem Cells market, 2014 – 2025 (USD Million)
8.6 Neurobiology
8.6.1 Neurobiology market, 2014 – 2025 (USD Million)
8.7 Others
8.7.1 Others market, 2014 – 2025 (USD Million)
Chapter 9 Research Antibodies Market: End – use Estimates & Trend Analysis
9.1 Research antibodies Market: End – use Movement Analysis
9.2 Academic & Research Institutes
9.2.1 Academic & research institutes market, 2014 – 2025 (USD Million)
9.3 Contract Research Organizations
9.3.1 Contract research organizations market, 2014 – 2025 (USD Million)
9.4 Pharmaceutical & Biotechnological Companies
9.4.1 Pharmaceutical & biotechnology companies market, 2014 – 2025 (USD Million)
Chapter 10 Research Antibodies Market: Regional Estimates & Trend Analysis, by Product, Type, Technology, Source, Application, End – use
10.1 Research Antibodies Market Share By Region, 2016 & 2025
10.2 North America
10.2.1 North America research antibodies market, 2014 – 2025 (USD Million)
10.2.2 U.S.
10.2.2.1 U.S. research antibodies market, 2014 – 2025 (USD Million)
10.2.3 Canada
10.2.3.1 Canada research antibodies market, 2014 – 2025 (USD Million)
10.3 Europe
10.3.1 Europe research antibodies market, 2014 – 2025 (USD Million)
10.3.2 U.K.
10.3.2.1 U.K. research antibodies market, 2014 – 2025 (USD Million)
10.3.3 Germany
10.3.3.1 Germany research antibodies market, 2014 – 2025 (USD Million)
10.4 Asia Pacific
10.4.1 Asia Pacific research antibodies market, 2014 – 2025 (USD Million)
10.4.2 Japan
10.4.2.1 Japan research antibodies market, 2014 – 2025 (USD Million)
10.4.3 China
10.4.3.1 China research antibodies market, 2014 – 2025 (USD Million)
10.4.4 India
10.4.4.1 India research antibodies market, 2014 – 2025 (USD Million)
10.5 Latin America
10.5.1 Latin America research antibodies market, 2014 – 2025 (USD Million)
10.5.2 Brazil
10.5.2.1 Brazil research antibodies market, 2014 – 2025 (USD Million)
10.5.3 Mexico
10.5.3.1 Mexico research antibodies market, 2014 – 2025 (USD Million)
10.6 MEA
10.6.1 MEA research antibodies market, 2014 – 2025 (USD Million)
10.6.2 South Africa
10.6.2.1 South Africa research antibodies market, 2014 – 2025 (USD Million)
Chapter 11 Competitive Landscape
11.1 List of Market Players
11.2 Company Profiles
11.2.1 Abcam PLC
11.2.1.1 Company overview
11.2.1.2 Financial Performance
11.2.1.3 Product Benchmarking
11.2.1.4 Strategic Initiatives
11.2.2 Bio – Rad Laboratories
11.2.2.1 Company Overview
11.2.2.2 Financial Performance
11.2.2.3 Product Benchmarking
11.2.3 BD
11.2.3.1 Company Overview
11.2.3.2 Financial Performance
11.2.3.3 Product Benchmarking
11.2.4 Merck Millipore (Danaher)
11.2.4.1 Company Overview
11.2.4.2 Financial Performance
11.2.4.3 Product Benchmarking
11.2.5 Lonza Group
11.2.5.1 Company overview
11.2.5.2 Financial performance
11.2.5.3 Geographic Foothold
11.2.5.4 Product benchmarking
11.2.6 Thermo Fisher Scientific
11.2.6.1 Company overview
11.2.6.2 Financial performance
11.2.6.3 Geographic Foothold
11.2.6.4 Product benchmarking
11.2.6.5 Strategic initiatives
11.2.7 Cell Signalling Technology, Inc.
11.2.7.1 Company overview
11.2.7.2 Product benchmarking
11.2.7.3 Strategic initiatives
11.2.8 F.Hoffmann La Roche Ltd.
11.2.8.1 Company overview
11.2.8.2 Financial performance
11.2.8.3 Product benchmarking
11.2.8.4 Strategic initiatives
11.2.9 Agilent Technologies
11.2.9.1 Company overview
11.2.9.2 Financial performance
11.2.9.3 Product benchmarking
11.2.10 PerkinElmer, Inc.
11.2.10.1 Company overview
11.2.10.2 Financial performance
11.2.10.3 Product benchmarking
11.2.10.4 Strategic initiatives

List of Tables

TABLE 1 Country share estimation
TABLE 2 North America research antibodies market, by product, 2014 - 2025 (USD Million)
TABLE 3 North America research antibodies market, by type, 2014 - 2025 (USD Million)
TABLE 4 North America research antibodies market, by technology, 2014 - 2025 (USD Million)
TABLE 5 North America research antibodies market, by source, 2014 - 2025 (USD Million)
TABLE 6 North America research antibodies market, by application, 2014 - 2025 (USD Million)
TABLE 7 North America research antibodies market, by end - use, 2014 - 2025 (USD Million)
TABLE 8 U.S. research antibodies market, by product, 2014 - 2025 (USD Million)
TABLE 9 U.S. research antibodies market, by type, 2014 - 2025 (USD Million)
TABLE 10 U.S. research antibodies market, by technology, 2014 - 2025 (USD Million)
TABLE 11 U.S. research antibodies market, by source, 2014 - 2025 (USD Million)
TABLE 12 U.S. research antibodies market, by application, 2014 - 2025 (USD Million)
TABLE 13 U.S. research antibodies market, by end - use, 2014 - 2025 (USD Million)
TABLE 14 Canada research antibodies market, by product, 2014 - 2025 (USD Million)
TABLE 15 Canada research antibodies market, by type, 2014 - 2025 (USD Million)
TABLE 16 Canada research antibodies market, by technology, 2014 - 2025 (USD Million)
TABLE 17 Canada research antibodies market, by source, 2014 - 2025 (USD Million)
TABLE 18 Canada research antibodies market, by application, 2014 - 2025 (USD Million)
TABLE 19 Canada research antibodies market, by end - use, 2014 - 2025 (USD Million)
TABLE 20 Europe research antibodies market, by product, 2014 - 2025 (USD Million)
TABLE 21 Europe research antibodies market, by type, 2014 - 2025 (USD Million)
TABLE 22 Europe research antibodies market, by technology, 2014 - 2025 (USD Million)
TABLE 23 Europe research antibodies market, by source, 2014 - 2025 (USD Million)
TABLE 24 Europe research antibodies market, by application, 2014 - 2025 (USD Million)
TABLE 25 Europe research antibodies market, by end - use, 2014 - 2025 (USD Million)
TABLE 26 U.K. research antibodies market, by product, 2014 - 2025 (USD Million)
TABLE 27 U.K. research antibodies market, by type, 2014 - 2025 (USD Million)
TABLE 28 U.K. research antibodies market, by technology, 2014 - 2025 (USD Million)
TABLE 29 U.K. research antibodies market, by source, 2014 - 2025 (USD Million)
TABLE 30 U.K. research antibodies market, by application, 2014 - 2025 (USD Million)
TABLE 31 U.K. research antibodies market, by end - use, 2014 - 2025 (USD Million)
TABLE 32 Germany research antibodies market, by product, 2014 - 2025 (USD Million)
TABLE 33 Germany research antibodies market, by type, 2014 - 2025 (USD Million)
TABLE 34 Germany research antibodies market, by technology, 2014 - 2025 (USD Million)
TABLE 35 Germany research antibodies market, by source, 2014 - 2025 (USD Million)
TABLE 36 Germany research antibodies market, by application, 2014 - 2025 (USD Million)
TABLE 37 Germany research antibodies market, by end - use, 2014 - 2025 (USD Million)
TABLE 38 Asia Pacific research antibodies market, by product, 2014 - 2025 (USD Million)
TABLE 39 Asia Pacific research antibodies market, by type, 2014 - 2025 (USD Million)
TABLE 40 Asia Pacific research antibodies market, by technology, 2014 - 2025 (USD Million)
TABLE 41 Asia Pacific research antibodies market, by source, 2014 - 2025 (USD Million)
TABLE 42 Asia Pacific research antibodies market, by application, 2014 - 2025 (USD Million)
TABLE 43 Asia Pacific research antibodies market, by end - use, 2014 - 2025 (USD Million)
TABLE 44 Japan research antibodies market, by product, 2014 - 2025 (USD Million)
TABLE 45 Japan research antibodies market, by type, 2014 - 2025 (USD Million)
TABLE 46 Japan research antibodies market, by technology, 2014 - 2025 (USD Million)
TABLE 47 Japan research antibodies market, by source, 2014 - 2025 (USD Million)
TABLE 48 Japan research antibodies market, by application, 2014 - 2025 (USD Million)
TABLE 49 Japan research antibodies market, by end - use, 2014 - 2025 (USD Million)
TABLE 50 China research antibodies market, by product, 2014 - 2025 (USD Million)
TABLE 51 China research antibodies market, by type, 2014 - 2025 (USD Million)
TABLE 52 China research antibodies market, by technology, 2014 - 2025 (USD Million)
TABLE 53 China research antibodies market, by source, 2014 - 2025 (USD Million)
TABLE 54 China research antibodies market, by application, 2014 - 2025 (USD Million)
TABLE 55 China research antibodies market, by end - use, 2014 - 2025 (USD Million)
TABLE 56 India research antibodies market, by product, 2014 - 2025 (USD Million)
TABLE 57 India research antibodies market, by type, 2014 - 2025 (USD Million)
TABLE 58 India research antibodies market, by technology, 2014 - 2025 (USD Million)
TABLE 59 India research antibodies market, by source, 2014 - 2025 (USD Million)
TABLE 60 India research antibodies market, by application, 2014 - 2025 (USD Million)
TABLE 61 India research antibodies market, by end - use, 2014 - 2025 (USD Million)
TABLE 62 Latin America research antibodies market, by product, 2014 - 2025 (USD Million)
TABLE 63 Latin America research antibodies market, by type, 2014 - 2025 (USD Million)
TABLE 64 Latin America research antibodies market, by technology, 2014 - 2025 (USD Million)
TABLE 65 Latin America research antibodies market, by source, 2014 - 2025 (USD Million)
TABLE 66 Latin America research antibodies market, by application, 2014 - 2025 (USD Million)
TABLE 67 Latin America research antibodies market, by end - use, 2014 - 2025 (USD Million)
TABLE 68 Brazil research antibodies market, by product, 2014 - 2025 (USD Million)
TABLE 69 Brazil research antibodies market, by type, 2014 - 2025 (USD Million)
TABLE 70 Brazil research antibodies market, by technology, 2014 - 2025 (USD Million)
TABLE 71 Brazil research antibodies market, by source, 2014 - 2025 (USD Million)
TABLE 72 Brazil research antibodies market, by application, 2014 - 2025 (USD Million)
TABLE 73 Brazil research antibodies market, by end - use, 2014 - 2025 (USD Million)
TABLE 74 Mexico research antibodies market, by product, 2014 - 2025 (USD Million)
TABLE 75 Mexico research antibodies market, by type, 2014 - 2025 (USD Million)
TABLE 76 Mexico research antibodies market, by technology, 2014 - 2025 (USD Million)
TABLE 77 Mexico research antibodies market, by source, 2014 - 2025 (USD Million)
TABLE 78 Mexico research antibodies market, by application, 2014 - 2025 (USD Million)
TABLE 79 Mexico research antibodies market, by end - use, 2014 - 2025 (USD Million)
TABLE 80 MEA research antibodies market, by product, 2014 - 2025 (USD Million)
TABLE 81 MEA research antibodies market, by type, 2014 - 2025 (USD Million)
TABLE 82 MEA research antibodies market, by technology, 2014 - 2025 (USD Million)
TABLE 83 MEA research antibodies market, by source, 2014 - 2025 (USD Million)
TABLE 84 MEA research antibodies market, by application, 2014 - 2025 (USD Million)
TABLE 85 MEA research antibodies market, by end - use, 2014 - 2025 (USD Million)
TABLE 86 South Africa research antibodies market, by product, 2014 - 2025 (USD Million)
TABLE 87 South Africa research antibodies market, by type, 2014 - 2025 (USD Million)
TABLE 88 South Africa research antibodies market, by technology, 2014 - 2025 (USD Million)
TABLE 89 South Africa research antibodies market, by source, 2014 - 2025 (USD Million)
TABLE 90 South Africa research antibodies market, by application, 2014 - 2025 (USD Million)
TABLE 91 South Africa research antibodies market, by end - use, 2014 - 2025 (USD Million)
TABLE 92 List of Market Players

List of Figures

FIG. 1 Market summary
FIG. 2 Market trends & outlook
FIG. 3 Market segmentation & scope
FIG. 4 Market driver relevance analysis (Current & future impact)
FIG. 5 Market restraint relevance analysis (Current & future impact)
FIG. 6 Penetration & growth prospect mapping
FIG. 7 Research antibodies SWOT Analysis, By Factor (Political & legal, economic and technological)
FIG. 8 Porter’s Five Forces Analysis
FIG. 9 Research antibodies market, product outlook: Key takeaways
FIG. 10 Research antibodies market: Product movement analysis
FIG. 11 Primary antibodies market, 2014 - 2025 (USD Million)
FIG. 12 Secondary antibodies market, 2014 - 2025 (USD Million)
FIG. 13 Research antibodies market, type outlook: Key takeaways
FIG. 14 Research antibodies market: Type movement analysis
FIG. 15 Monoclonal antibodies market, 2014 - 2025 (USD Million)
FIG. 16 Polyclonal antibodies market, 2014 - 2025 (USD Million)
FIG. 17 Research antibodies market, technology outlook: Key takeaways
FIG. 18 Research antibodies market: Technology movement analysis
FIG. 19 Immunohistochemistry market, 2014 - 2025 (USD Million)
FIG. 20 Immunofluorescence market, 2014 - 2025 (USD Million)
FIG. 21 Western blotting market, 2014 - 2025 (USD Million)
FIG. 22 Flow cytometry market, 2014 - 2025 (USD Million)
FIG. 23 Immunoprecipitation market, 2014 - 2025 (USD Million)
FIG. 24 ELISA market, 2014 - 2025 (USD Million)
FIG. 25 Others market, 2014 - 2025 (USD Million)
FIG. 26 Research antibodies market, source outlook: Key takeaways
FIG. 27 Research antibodies market: Source movement analysis
FIG. 28 Mouse market, 2014 - 2025 (USD Million)
FIG. 29 Rabbit market, 2014 - 2025 (USD Million)
FIG. 30 Goat market, 2014 - 2025 (USD Million)
FIG. 31 Others market, 2014 - 2025 (USD Million)
FIG. 32 Research antibodies market, application outlook: Key takeaways
FIG. 33 Research antibodies market: Application movement analysis
FIG. 34 Infectious diseases market, 2014 - 2025 (USD Million)
FIG. 35 Immunology market, 2014 - 2025 (USD Million)
FIG. 36 Oncology market, 2014 - 2025 (USD Million)
FIG. 37 Stem cells market, 2014 - 2025 (USD Million)
FIG. 38 Neurobiology market, 2014 - 2025 (USD Million)
FIG. 39 Others market, 2014 - 2025 (USD Million)
FIG. 40 Research antibodies market, end - use outlook: Key takeaways
FIG. 41 Research antibodies market: End - use movement analysis
FIG. 42 Academic & research institutes market, 2014 - 2025 (USD Million)
FIG. 43 Contract research organizations market, 2014 - 2025 (USD Million)
FIG. 44 Pharmaceutical & biotechnology companies market, 2014 - 2025 (USD Million)
FIG. 45 Regional market place: Key takeaways
FIG. 46 Regional outlook, 2016 & 2025
FIG. 47 North America research antibodies market, 2014 - 2025 (USD Million)
FIG. 48 U.S. research antibodies market, 2014 - 2025 (USD Million)
FIG. 49 Canada research antibodies market, 2014 - 2025 (USD Million)
FIG. 50 Europe research antibodies market, 2014 - 2025 (USD Million)
FIG. 51 U.K. research antibodies market, 2014 - 2025 (USD Million)
FIG. 52 Germany research antibodies market, 2014 - 2025 (USD Million)
FIG. 53 Asia Pacific research antibodies market, 2014 - 2025 (USD Million)
FIG. 54 Japan research antibodies market, 2014 - 2025 (USD Million)
FIG. 55 China research antibodies market, 2014 - 2025 (USD Million)
FIG. 56 India research antibodies market, 2014 - 2025 (USD Million)
FIG. 57 Latin America research antibodies market, 2014 - 2025 (USD Million)
FIG. 58 Brazil research antibodies market, 2014 - 2025 (USD Million)
FIG. 59 Mexico research antibodies market, 2014 - 2025 (USD Million)
FIG. 60 MEA research antibodies market, 2014 - 2025 (USD Million)
FIG. 61 South Africa research antibodies market, 2014 - 2025 (USD Million)

★調査レポート[研究用抗体の世界市場:製品別、種類別(単クローン、多クローン)、技術別、ソース別、用途別(腫瘍学、神経生物学)、最終用途別、セグメント予測] (コード:GVIEW805075)販売に関する免責事項を必ずご確認ください。
★調査レポート[研究用抗体の世界市場:製品別、種類別(単クローン、多クローン)、技術別、ソース別、用途別(腫瘍学、神経生物学)、最終用途別、セグメント予測]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆